
Danish multinational Novo Nordisk has announced that they are increasing their stocks of insulin products to ensure that there are …

What does Brexit mean for drug safety in Europe and the United Kingdom? Louis Goss looks into Britain’s exit from …

Brexit took the top two spots this week after it was revealed that the EMA has awarded Britain’s MHRA just …
The US multinational Pfizer has said that Brexit will cost the company $100 million in costs associated with the transference …

The new September edition of Pharmafocus is now live and available to read online. We’re entering the final stretch as …

The EMA has awarded Britain’s regulatory body the MHRA just two contracts this year, as the European agency suggested that …

Eight months of 2018 down – where has the year gone? As we move from August into September, and a …

The British Government has published a document offering guidance as to what should be expected in the case of a …

Niall Dickson, co-chair of the Brexit Health Alliance has called for immediate comprehensive and effective plans for a no deal …

NHS Providers, the membership organisation and trade association for professionals working in the NHS, has warned that the NHS is …

There was some clarity on Brexit this week as the MHRA set out a plan for the implantation period set …

The head of the Association of the British Pharmaceutical Industry (ABPI) has warned that European governments have failed to recognise …

The UK Medicines and Healthcare products Regulatory Agency (MHRA) have released an update which sets out what pharmaceutical and healthcare …

Pfizer is considering joining AstraZeneca, Sanofi and MSD in stockpiling medicines in preparation for a hard Brexit, it has emerged. …

While average temperatures dropped to a comfortable 22 degrees, the past week has put the EMA in a sticky position …